| Date Filed | Type | Description |
| 08/21/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $8.46, valued at
$6.5k
Paid exercise price by delivering 2,868 shares
@ $8.46, valued at
$24.3k
Sold 20,000 shares
@ $8.07, valued at
$161.4k
Exercised 1,981 restricted stock units
@ $0
Exercised 7,363 restricted stock units
@ $0 |
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $6.69, valued at
$5.2k
Paid exercise price by delivering 1,912 shares
@ $6.69, valued at
$12.8k
Sold 20,000 shares
@ $7.19, valued at
$143.8k
Exercised 1,981 restricted stock units
@ $0
Exercised 4,908 restricted stock units
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/21/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $9.29, valued at
$185.8k
|
|
| 03/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/07/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 178,062 options to buy
@ $10.61, valued at
$1.9M
Granted 117,813 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $10.97, valued at
$8.5k
Sold 20,000 shares
@ $10.94, valued at
$218.8k
Exercised 1,981 restricted stock units
@ $0 |
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 1,081 shares
@ $13.5, valued at
$14.6k
Sold 11 shares
@ $13.51, valued at
$148.6 |
|
| 01/20/2023 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $11.03, valued at
$220.6k
|
|
| 12/20/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.38, valued at
$207.6k
|
|
| 11/22/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $14.75, valued at
$11.4k
Sold 20,000 shares
@ $14.66, valued at
$293.2k
Exercised 1,981 restricted stock units
@ $0 |
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $12.42, valued at
$248.4k
|
|
| 08/19/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 772 shares
@ $14.06, valued at
$10.9k
Sold 20,000 shares
@ $13.62, valued at
$272.4k
Exercised 1,981 restricted stock units
@ $0 |
|
| 07/20/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $11.83, valued at
$236.6k
|
|
| 06/22/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.06, valued at
$201.2k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.34, valued at
$206.8k
|
|
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Yan Ming (Chief Technology Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 14,706 shares
@ $15.01, valued at
$220.7k
Sold 5,294 shares
@ $15.37, valued at
$81.4k
|
|
| 02/14/2022 |
5
| Yan Ming (Chief Technology Officer) has filed a Form 5 on Cytek Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| Yan Ming reports a 6.1% stake in Cytek Biosciences, Inc. |
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
3
| Yan Ming (Chief Technology Officer) has filed a Form 3 on Cytek BioSciences, Inc. |